Clinicopathological implications of expressions of hypoxia-related molecules in esophageal superficial squamous cell carcinoma

Annals of Diagnostic Pathology

Volumn 14, Issue 1, 2010, Pages 23-29

  Ogane, Naoki ^a   Yasuda, Masanori ^b   Shimizu, Michio ^b   Miyazawa, Masaki ^c   Kamoshida, Shingo ^d   Ueda, Akiko ^a   Takata, Ken ^a   Sakuma, Yuji ^a   Miyagi, Yohei ^a   Kameda, Yoichi ^a  

^a KANAGAWA CANCER CENTER   (Japan)

^b SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KOBE UNIVERSITY   (Japan)

Author keywords

Esophagus; GLUT 1; HIF 1 ; RAC 1; Squamous cell carcinoma

Indexed keywords

GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; RAC1 PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANOXIA; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RAC1 GTP-BINDING PROTEIN;

EID: 73949140017     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2009.10.003     Document Type: Article

References (41)

1. Takubo K., Aida J., Sawade M., et al. Early squamous cell carcinoma of oesophagus: the Japanese viewpoint. Histopathology 51 (2007) 733-742
2. Japan Esophageal Society. Japanese Classification of Esophageal Cancer, 10th (2007), Kanehara Co., Ltd., Tokyo Japan
3. Semenza G.L. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 70 (2002) 1841-1843
4. Yasuda M., Miyazawa M., Fujita M., et al. Expression of hypoxia-inducible factor-1α (HIF-1α) and glucose transporter-1 (GLUT-1) in ovarian adenocarcinomas: Difference in hypoxic status depending on histological character. Oncol Rep 19 (2007) 111-116
5. Iida T., Yasuda M., Miyazawa M., et al. Hypoxic status in ovarian serous and mucinous tumors: Relationship between histological characteristics and HIF-1 alpha/GLUT-1 expression. Arch Gynecol Obstet 277 (2008) 539-546
6. Yasuda M., Ogane N., Hayashi H., et al. Glucose transporter-1 expression in the thyroid gland: Clinicopathological significance for papillary carcinoma. Oncol Rep 14 (2005) 1499-1504
7. Haber R.S., Rathan A., Weiser K.R., et al. GLUT-1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer 83 (1998) 34-40
8. Ogawa J., Inoue H., and koide S. Glucouse-transporter-type-I-gene amplification correlates with sialyl-Lewis-X synthesis and proliferation in lung cancer. Int J Cancer 74 (1997) 189-192
9. Cantuaria G., Fagotti A., Ferranina G., et al. GLUT-1 expression in ovarian carcinoma: association with survial and response to chemotherapy. Cancer 92 (2001) 1144-1150
10. Kuwamura T., Kusakabe T., Sugino T., et al. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. Cancer 92 (2001) 634-641
11. Nobes C., and Hall A. Regulation and function of the Rho subfamily of small GTPases. Curr Opin Genet Dev 4 (1994) 77-81
12. Qiu R.G., Chen J., McCormick F., et al. A role for Rho in Ras transformation. Proc Natl Acad Sci U S A 92 (1995) 11781-11785
13. Roux P., Gauthier-Rouviere C., Doucet-Brutin S., et al. The small GTPases Cdc42Hs, Rac1 and RhoG delineate Raf-independent pathways that cooperate to transform NIH3T3 cells. Curr Biol 7 (1997) 629-637
14. Clark E.A., Golub T.R., Lander E.S., et al. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406 (2000) 532-535
15. Ridley A.J. Rho GTPases and cell migration. J Cell Sci 114 (2001) 2713-2722
16. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13 (1999) 1501-1512
17. Robles A.I., Rodriguez-puebla M.L., Glick A.B., et al. Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo. Genes Dev 12 (1998) 2469-2474
18. Coleman M.L., and Olson M.F. Rho GTPase signaling pathways in the morphological changes associated with apoptosis. Cell Death Differ 9 (2002) 493-504
19. Pervaiz S., Cao J., Chao O.S., et al. Activation of the Rac GTPase inhibits apoptosis in human tumor cells. Oncogene 20 (2001) 6263-6268
20. Xue Y., Bi F., Zhang X., et al. Role of Rac1 and Cdc42 in hypoxia induced p53 and von Hippel-Lindau suppression and HIF1α activation. Int j Cancer 118 (2006) 2965-2972
21. Turcotte S., Desrosiers R.R., and Béliveau R. HIF-1alpha mRNA and protein upregulation involves Rho GTPase expression during hypoxia in renal cell carcinoma. J Cell Sci 116 (2003) 2247-2260
22. Hirota K., and Semenza G.L. Rac1 activity is required for the activation of hypoxia-inducible factor 1. J Biol Chem 24 (2001) 21166-21172
23. Kurokawa T., Miyamoto M., Kato K., et al. Overexpression of hypoxia-inducible factor-1 (HIF-1α) in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Br J Cancer 89 (2003) 1042-1047
24. Matsuyama T., Nakanishi K., Hayashi T., et al. Expression of hypoxia-inducible factor-1α in esophageal squamous cell carcinoma. Cance Sci 96 (2005) 176-182
25. Koukourakis M.I., Giatromanolaki A., Skarlatos J., et al. Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res 61 (2001) 1830-1832
26. Tohoma T., Okazumi S., Makino H., et al. Overexpression of glucose transporter 1 in esophageal squamous cell carcinoma: a marker for poor prognosis. Dis Esophagus 18 (2005) 185-189
27. Kato H., Takita J., Miyazaki T., et al. Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness. Anticancer Res 22 (2002) 2635-2640
28. Chino O., Kijima H., Shimada H., et al. Accumulation of p53 in esophageal squamous cell carcinoma. Int J Mol Med 8 (2001) 359-363
29. Hara T., Kijima H., Yamamoto S., et al. Ubiquitous p63 expression in human esophageal squamous cell carcinoma. Int J Mol Med 14 (2004) 169-173
30. Nadaoka J., Horikawa Y., Saito M., et al. Prognostic significance of HIF-1 alpha polymorphisms in transitional cell carcinoma of the bladder. Int J Cancer 122 (2008) 1297-1302
31. Sun H.C., Qiu Z.J., Liu J., et al. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis. J Oncol 30 (2007) 1359-1367
32. Mizokami K., Kakeji Y., Oda S., et al. Clinicopathologic significance of hypoxia-inducible factor 1alpha overexpression in gastric carcinomas. J Surg Oncol 94 (2006) 149-154
33. Klatte T., Seligson D.B., Riggs S.B., et al. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma. Clin Cancer Res 13 (2007) 7388-7393
34. Bos R., van Diest P.J., van der Groep P., et al. Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related. Breast Cancer Res 6 (2004) 450-459
35. Osada R., Horiuchi A., Kikuchi N., et al. Expression of hypoxia-inducible factor 1 alpha, hypoxia-inducible factor 2 alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1 alpha is an independent prognostic factor in ovarian carcinoma. Hum Pathol 38 (2007) 310-320
36. Birner P., Schindl M., Obermair A., et al. Expression of hypoxia-inducible factor 1 alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Cancer Res 60 (2000) 4610-4616
37. Nakayama K., Kanzaki A., Hata K., et al. Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinoma. Cancer Lett 176 (2002) 215-223
38. Miyazawa M., Yasuda M., Fujita M., et al. Therapeutic strategy targeting at mTOR-HIF-1α-VEGF pathway for ovarian clear cell adenocarcinoma. Pathol Int 59 (2009) 19-27
39. Miyazawa M., Yasuda M., Fujita M., et al. Association of hypoxia-inducible factor-1 expression with histology in epithelial ovarian tumors: a quantitative analysis of HIF-1. Arch Gynecol Obstet 279 (2009) 789-796
40. Zohn I.M., Campbell S.L., Khosravi-far R., et al. Rho family proteins and Ras transformation: RHad less traveled gets congested. Oncogene 17 (1998) 1415-1438
41. Liu S.Y., Yen C.Y., Yang S.C., et al. Overexpression of Rac-1 Small GTPase Binding Protein in Oral Squamous cell Carcinoma. J Oral Maxillofac Surg 62 (2004) 702-707